SPIRONOLACTONE
HYPERTENSION·+6
ACTAVIS PHARMA,
Indication
Heart failure with reduced ejection fraction
Heart failure with reduced ejection fraction is a chronic cardiovascular syndrome characterized by the heart's inability to pump sufficient oxygenated blood to meet systemic metabolic demands. Read more about Heart failure with reduced ejection fraction
33 drugs 33 manufacturers
Drugs that treat it
Common Heart failure with reduced ejection fraction therapies.
SPIRONOLACTONE
DIURETICS·HYPERTENSION·+6
CADISTA PHARMAC
ALDACTONE (spironolactone)
DIURETICS·HYPERTENSION·+6
Pfizer Laboratories
SPIRONOLACTONE
DIURETICS·HYPERTENSION·+6
ZYDUS PHARMACEU
VERQUVO (vericiguat)
SOLUBLE GUANYLATE CYCLASE (SGC) STIMULATORS·HEART FAILURE WITH REDUCED EJECTION FRACTION
Merck Sharp & Dohme
SPIRONOLACTONE
DIURETICS·HYPERTENSION·+6
Major Pharamceuticals
SPIRONOLACTONE
DIURETICS·HYPERTENSION·+6
BLENHEIM PHARMA
SPIRONOLACTONE
DIURETICS·HYPERTENSION·+6
NORTHSTAR RX LL
SPIRONOLACTONE
DIURETICS·HYPERTENSION·+6
A-S MEDICATION
Filter & compare in the drug finder →Opens the drug finder with Heart failure with reduced ejection fraction preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHeart failure with reduced ejection fraction is a chronic cardiovascular syndrome characterized by the heart's inability to pump sufficient oxygenated blood to meet systemic metabolic demands.
Affecting the cardiovascular system in pediatric and adult populations, it is clinically defined by signs and symptoms of heart failure alongside left ventricular systolic dysfunction, specifically a left ventricular ejection fraction of 40% or less.
Pathophysiologically, it involves progressive left ventricular dilatation, adverse myocardial remodeling, and neurohormonal activation that lead to impaired contractile function, elevated intracardiac filling pressures, pulmonary and systemic venous congestion, and reduced cardiac output.
- nih.gov
Heart failure with reduced ejection fraction is a chronic cardiovascular syndrome characterized by the heart's inability to pump sufficient oxygenated blood to meet systemic metabolic demands Affecting the cardiovascular system in pediatric and adult populations, it is clinically defined by signs and symptoms of heart failure alongside left ventricular systolic dysfunction, specifically a left ventricular ejection fraction of 40% or less Pathophysiologically, it involves progressive left ventric...
- nih.gov
Heart failure with reduced ejection fraction is a chronic cardiovascular syndrome characterized by the heart's inability to pump sufficient oxygenated blood to meet systemic metabolic demands Affecting the cardiovascular system in pediatric and adult populations, it is clinically defined by signs and symptoms of heart failure alongside left ventricular systolic dysfunction, specifically a left ventricular ejection fraction of 40% or less Pathophysiologically, it involves progressive left ventric...
- nih.gov
Pathophysiologically, it involves progressive left ventricular dilatation, adverse myocardial remodeling, and neurohormonal activation that lead to impaired contractile function, elevated intracardiac filling pressures, pulmonary and systemic venous congestion, and reduced cardiac output
Personalize your experience
Follow Heart failure with reduced ejection fraction and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.